BAX
Baxter International·NYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 2
Bearish signal 2
Ample Liquidity
Significant Net Income Decline
Revenue Beats Expectation
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About BAX
Baxter International Inc.
A commercial-stage company focused on transforming the lives of people with fluid overload
Healthcare Equipment and Supplies
--
05/15/1961
New York Stock Exchange
38,000
12-31
Common stock
One Baxter Parkway, Deerfield, Illinois, 60015
Development, production and sales of medical equipment and products
Baxter International Inc. was incorporated in 1931 under the laws of the State of Delaware. The company offers a broad range of basic healthcare products, including sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapy; inhaled anesthesia; generic injections; surgical hemostatic and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technology; and respiratory health equipment.
Earnings Call
Q1/2025
Estimate EPS0.48
Actual EPS0.55
Estimate Revenue2.59B
Actual Revenue2.63B
Baxter's Q1 2025 Earnings Call: Key Contradictions on HST Recovery, IV Fluid Dynamics, and Hurricane Impacts
May 06,2025 07:34
Earnings Decrypt
Earnings Decrypt
Q2/2025
Estimate EPS0.61
Actual EPS0.59
Estimate Revenue2.82B
Actual Revenue2.81B
Baxter's Q2 2025 Earnings Call: Navigating Contradictions in Novum Impact, Revenue Guidance, and Fluid Demand
Jul 31,2025 12:31
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
BAX has released its 2025 Q3 earnings. EPS was reported at 0.69, versus the expected 0.6, beating expectations. The chart below visualizes how BAX has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
BAX has released its 2025 Q3 earnings report, with revenue of 2.83B, reflecting a YoY change of 5.04%, and net profit of -46.00M, showing a YoY change of -131.94%. The Sankey diagram below clearly presents BAX's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
